Cardlytics, Inc. (NASDAQ:CDLX) Receives $6.92 Average Price Target from Analysts

Cardlytics, Inc. (NASDAQ:CDLX) has been assigned a consensus rating of “Hold” from the seven ratings firms that are presently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, five have assigned a hold rating and one has given a strong buy rating to the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is $6.92.

A number of research analysts have recently issued reports on CDLX shares. Craig Hallum upgraded Cardlytics from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, November 6th. Needham & Company LLC reiterated a “hold” rating on shares of Cardlytics in a research report on Friday, January 17th.

Insider Activity at Cardlytics

In other Cardlytics news, CEO Amit Gupta sold 15,160 shares of Cardlytics stock in a transaction that occurred on Friday, January 24th. The stock was sold at an average price of $3.92, for a total transaction of $59,427.20. Following the transaction, the chief executive officer now owns 215,494 shares of the company’s stock, valued at $844,736.48. The trade was a 6.57 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CFO Alexis Desieno sold 24,778 shares of the business’s stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $3.40, for a total value of $84,245.20. Following the completion of the transaction, the chief financial officer now directly owns 140,948 shares in the company, valued at approximately $479,223.20. The trade was a 14.95 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 111,454 shares of company stock worth $391,864 in the last three months. 4.40% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of CDLX. Atom Investors LP acquired a new position in shares of Cardlytics in the third quarter valued at approximately $33,000. Tallon Kerry Patrick acquired a new position in Cardlytics during the fourth quarter worth $37,000. ProShare Advisors LLC acquired a new position in Cardlytics during the fourth quarter worth $43,000. SG Americas Securities LLC acquired a new position in Cardlytics during the third quarter worth $45,000. Finally, Intech Investment Management LLC acquired a new position in Cardlytics during the third quarter worth $47,000. Institutional investors and hedge funds own 68.10% of the company’s stock.

Cardlytics Trading Down 2.9 %

Cardlytics stock opened at $2.67 on Monday. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 2.40. Cardlytics has a 12 month low of $2.60 and a 12 month high of $20.52. The stock’s 50 day simple moving average is $3.36 and its two-hundred day simple moving average is $3.62. The firm has a market cap of $135.69 million, a PE ratio of -0.44 and a beta of 1.54.

About Cardlytics

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.